Pioglitazone hydrochloride and glimepiride

Sandoz Inc🇺🇸 United States

FDA Page

Effective Date: Jun 18, 2018
Approval ID: 2aab19ce-1e5e-44ee-85e5-d8f125f9bb1a
Products: 2 registered
Version: 10

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use PIOGLITAZONE AND GLIMEPIRIDE TABLETS safely and effectively. See full prescribing information for PIOGLITAZONE AND GLIMEPIRIDE TABLETS. PIOGLITAZONE and GLIMEPIRIDE tablets, for oral useInitial U.S. Approval: 2006

Quick Stats

Total Products2

Labelers2

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.